TNFRSF9 and neoplasm: When we tested the anti-tumor activity of AbTCR-T cells both in vitro and with tumor xenograft models, AbTCR-T cells maintain comparable anti-tumor potency to ET190L1-CAR and CD137-based CTL019-T cells (Figs. 3c, 5a–c).